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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess the effectiveness of case management for integrated care of frail older people compared to usual care.
B A C K G R O U N D
Demographic changes and advances in medical care and tech-
nology have led to an ageing population. Despite gains in life
expectancy, compression of morbidity in later life has not been
achieved, meaning that although growing numbers of older peo-
ple are living longer, they are doing so with one or more long-
term conditions (Beard 2016). A key driving force for interna-
tional policy agendas worldwide is to improve the quality, effi-
ciency and safety of health and care services through the delivery
of effective integrated care systems (World Health Organization
2016). Integrated care can be broadly defined as “an organising
principle for care delivery that aims to improve patient care and ex-
perience through improved coordination” (Shaw 2011), and such
approaches are being increasingly implemented as a key policy in
many countries. This review will focus on case management as
one service model for delivering integrated care, among others.
Case management has gained traction with policy makers recently
as a method of improving quality of care and related outcomes
for populations at high risk of declines in health and wellbeing
and emergency and hospital admission (Ross 2011), with themost
vulnerable people in this group classified as frail (Goodwin 2014).
Description of the condition
This Cochrane Review focuses on frail older people. Frailty is de-
fined as an age-related reduction in reserve capacity of multiple
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physiological systems resulting in an increased risk of a sudden
decline in health status, usually triggered by minor stress such as
a fall or infection (Campbell 1997; Clegg 2013). The prevalence
of frailty is higher among women than men, and gradually in-
creases with age: 4% among older people aged 65 to 69 years;
7% between 70 and74 years; 9% between 75 and 79 years; 16%
between 80 and 84 years; and 26% for those aged 85 years and
over (Collard 2012; Clegg 2013). Frailty has also been found to
be associated with lower socioeconomic status (Gu 2016). Older
people with frailty commonly experience complex health and psy-
chosocial needs (Manthorpe 2015), and multimorbidity (Hewitt
2016). They are often high users of health and social care services,
with associated high costs (Bock 2016), but are also a population
group at risk of experiencing reduced co-ordination and quality
of care due to fragmented service provision (Ament 2014; Oliver
2014; Andreasen 2015).
Description of the intervention
The intervention to be evaluated is case management as a strat-
egy for integrated care. In this review we define case manage-
ment as a community-based intervention which focuses on the
planning, provision and co-ordination of health and social care to
meet the needs of the older person with frailty (Oeseburg 2009;
Reilly 2015). Case management interventions are multi-faceted
and comprise multiple components, including case-finding, com-
prehensive assessment, care provision, planning and care giving,
care co-ordination, monitoring and evaluation (Gagnon 1999;
Ross 2011; Sandberg 2014). Such interventions are typically led
by a nurse, social worker or allied healthcare professional (e.g.
physiotherapist), with the support of amultidisciplinary team, and
are delivered in community care settings, i.e. the individual’s own
home environment and not an acute or residential care setting
(Reilly 2015).
How the intervention might work
Frail older people commonly have health and social care needs
(Manthorpe 2015), but experience reduced co-ordination of care
due to fragmented service provision (Ament 2014; Oliver 2014;
Andreasen 2015). Case management approaches as a strategy for
improving health and social care integration aim to improve co-
ordination of care to meet the holistic needs (physical, psycholog-
ical and social) of individuals, thus reducing the fragmentation of
health and social care services, and resulting in better patient and
service outcomes.
A number of randomised trials of case management approaches
to support frail older people have been conducted, but evidence
from these studies has not been systematically synthesised. Some
studies have found that case management for frail older people
improves independence in activities of daily living (Eklund 2013),
increases patient satisfaction (Berglund 2015), reduces mobility-
related disability (Fairhall 2012), delays admission to hospital or
a nursing home (Bernabei 1998; Oeseburg 2009), reduces health-
care service use (Bernabei 1998; Oeseburg 2009; Sandberg 2015),
and lowers costs (Bernabei 1998; Oeseburg 2009). Other studies
have found no effects on improving levels of disability (Metzelthin
2013), quality of life and functional status, reducing admission
to hospital or length of hospital stay (Gagnon 1999), or prevent-
ing adverse outcomes (Ruikes 2016). One study reported an in-
crease in readmission rates to an EmergencyDepartment (Gagnon
1999). Evidence from a recent Cochrane Review has found that
case management interventions delivered to people with dementia
and their carers improves some outcomes, including reducing rates
of care home admission and healthcare costs in the medium term,
and improving psychosocial outcomes for carers (Reilly 2015).
Given emerging positive benefits of delivering some services closer
to the frail older person’s home environment, and the older per-
son’s preference for this (Oliver 2014), it is important to examine
the benefits of case management interventions for integrated care
of frail older people.
There is currently limited understanding of how case management
approaches as a strategy for integrated care for frail older people
might work. A number of factors are likely to influence this. Frail
older people’s health and social care needs will depend on the de-
gree of frailty, disability and level of social support available. It is
likely that individuals with different degrees of frailty will require
different formulations and levels of intensity of case management,
which will likely have different impacts on the frail older person,
carer, providers and services (e.g. level and nature of carer and
provider support required, with implications for health and social
care utilisation and costs). As the available health and social care
service provision, support and integration will vary between coun-
tries, this will likely influence how case management for frail older
people might work. Finally, as frailty is more prevalent among par-
ticular subgroups - namely those of lower socioeconomic status
(Gu 2016),older age and women (Collard 2012) - these charac-
teristics are also likely to influence how case management for this
population might work.
Why it is important to do this review
As integrated care is being implemented as a key policy interna-
tionally, providing the evidence of impact from randomised trials
of case management interventions to improve integrated care for
frail older people would be valuable for health care decision mak-
ers. Thus the primary aim of this Cochrane Review is to evaluate
the effectiveness of case management for integrated care of frail
older people compared to usual care. This review will evaluate ef-
fectiveness by examining the impact of case management on pa-
tient, carer, provider and service outcomes, as well as any adverse
effects. Another reason for conducting this review is to identify
which elements of these interventions drive the desired effect, and
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also which patient cohorts might experience most benefit from
such interventions. Using a systematic approach to establish the
effects of this intervention would be useful for a range of stake-
holders, including health and social care providers, service users
and carers, commissioners of services, policy makers and academic
researchers working in this field. Testing this in a systematic review
and providing a synthesis of what (if anything) we know works
about case management for integrated care of frail older people
is essential to ensure that policy makers, commissioners of ser-
vices, and practitioners deliver clinically improved interventions
and achieve better value outcomes.
O B J E C T I V E S
To assess the effectiveness of case management for integrated care
of frail older people compared to usual care.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include randomised trials (RTs), of both individual and
cluster design, that compare case management for integrated care
of frail older people with usual care. An initial scoping of the
literature indicates sufficient numbers of RTs to include in a meta-
analysis in this review. We will include all trials, however old,
conducted in high-, middle- and low-income countries.
We will include full-text, peer-reviewed publications, conference
abstracts (with a view to identifying full studies), and unpublished
data.Wewill include studies irrespective of their publication status
and language of publication.
We will exclude the following types of study designs.
• Studies involving non-randomised designs (e.g. non-RT,
interrupted time series designs).
• Studies involving observational methods only.
Types of participants
We will include men and women aged 65 years and over, who
meet the following criteria.
• Identified as frail using criteria defined by trial authors.
• Living in a community setting, i.e. individuals living in their
own home, retirement housing or sheltered accommodation, but
excluding those living in a nursing or residential care setting.
• Not medically unwell, i.e. not receiving acute medical care.
Two dominant models of frailty are the phenotypical (Fried 2001),
or accumulative deficit (Searle 2008),models of frailty. The former
categorises frailty as a clinical syndrome, specifically meeting three
or more of the following five criteria: weight loss, exhaustion,
weak grip strength, slowwalking speed, lowphysical activity (Fried
2001). The accumulative deficit model conceptualises frailty as
a multidimensional state, including physical, psychological and
social domains of function, using a proportion of health deficits
from the number of problems assessed (Searle 2008). We will use
criteria to define frailty as defined by trial authors of included
studies, which may include validated measures to identify frailty
based on one of the models mentioned above.
Types of interventions
We will include all trials comparing case management for inte-
grated care of frail older people with usual care. To be included,
the intervention should meet the following criteria,
• Led by a single health or social care professional who has a
role in care delivery for older people with complex needs,
supported by a multidisciplinary team (MDT). This can include
a nurse, social worker or allied healthcare professional.
• Focused on the planning, provision and co-ordination of
health and social care to meet the needs of the older person with
frailty.
• Delivered in community care settings, and not acute care
settings, with no minimum or maximum follow-up period to
assess outcomes.
The comparison for this review will be:
• case management compared with usual care, as described by
trial authors, defined as non-case-management standard care for
frail older people delivered in community care settings. This
usually involves identification of frailty and related management
and care planning by a General Practitioner (GP) in primary
care, but does not focus on health and social care integration for
this population.
Wewill provide a description of care for the intervention and usual
care in the ’Characteristics of included studies’ table, using the
template for intervention description and replication (TIDieR)
checklist (Hoffmann 2014).
Types of outcome measures
Primary outcomes
• Death (all types of analysis, i.e. rates, time to death, risk,
coherence of place of death with patient preference), as defined
by trial authors. We justify including death as a primary outcome
because frailty is the leading cause of death in older people
(Clegg 2013).
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• Living at home or change in place of residence (e.g. nursing
or residential care) at follow-up.
• Quality of life, as defined by trial authors.
• Serious adverse events (e.g. hospitalisation from falls or
fracture, permanent disability or death).
Secondary outcomes
• Change in function (increase or decrease in level of
independence in instrumental activities of daily life), as defined
by trial authors.
• Change (increase or decrease) in health and social care
utilisation and costs (e.g. due to admission or readmission to an
emergency department or hospital ward, increased hospital
length of stay, admission to nursing or residential care).
• Patient, carer (e.g. carer strain or burden) and provider
experience and acceptability, as defined by trial authors
Search methods for identification of studies
Electronic searches
We will develop the search terms with the Cochrane Effective
Practice and Organisation of Care (EPOC) Group’s Information
Specialist. We will search the Cochrane Database of Systematic
Reviews (CDSR) and the Database of Abstracts of Reviews of
Effects (DARE) for related systematic reviews.
We will search the following databases for primary studies, from
inception to the date of search.
• Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library, which will also include
the Cochrane EPOC Group Register.
• MEDLINE Ovid, 1946 to date of search.
• Embase Ovid, 1974 to date of search.
• CINAHL EBSCO (Cumulative Index to Nursing and
Allied Health Literature), 1980 to date of search.
• Health Systems Evidence (https://www.pdq-evidence.org/),
to date of search.
• PDQ Evidence ( https://www.pdq-evidence.org/), to date
of search.
Search terms will be comprised of keywords and controlled vo-
cabulary terms. We will not apply any limits on language and we
will search all databases from inception to the date of search. See
Appendix 1 for the proposed MEDLINE search strategy, which
we will adapt for other databases.
Searching other resources
Trial registries
• World Health Organization ( WHO) International Clinical
Trials Registry Platform ( ICTRP) ( www.who.int/ictrp), to date
of search.
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov ( www.clinicaltrials.gov), to date of search.
• McMaster Ageing Portal (
www.mcmasteroptimalaging.org/), to date of search.
Grey literature
We will conduct a grey literature search to identify studies not
indexed in the databases listed above.
• King’s Fund Library Database ( https://www.pdq-
evidence.org/), to date of search.
• British Geriatrics Society ( https://www.pdq-evidence.org/),
to date of search.
• American Geriatrics Society ( https://www.pdq-
evidence.org/), to date of search.
We will also review reference lists of all included studies and rele-
vant systematic reviews for additional potentially eligible primary
studies. We will contact researchers with expertise relevant to the
review topic to identify further unpublished literature. We will
conduct cited reference searches for all included studies in ISIWeb
of Science, if the number of included studies is amanageable num-
ber (i.e. below 10), and screen individual journals and conference
proceedings (e.g. through handsearching). We will provide appen-
dices for all strategies used, including a list of sources screened and
relevant primary studies reviewed.
Data collection and analysis
Selection of studies
We will download all titles and abstracts retrieved by electronic
searching to a reference management database and remove dupli-
cates. Six review authors (ES, AZ, ZK, JW, KS, JS) will indepen-
dently screen titles and abstracts for inclusion. This will involve
one author (ES) independently screening all titles and abstracts for
inclusion, and five authors independently screening a proportion
of titles and abstracts for inclusion, namely AZ (30%), ZK (20%),
JW (20%), KS (20%) and JS (10%). We will retrieve the full-text
publications of relevant studies and five review authors (ES, AZ,
ZK, JW, KS) will independently screen the full-text and identify
studies for inclusion, as well as identify and record reasons for ex-
clusion of the ineligible studies. This will involve one author (ES)
independently screening the relevant full-text study publications,
and four authors independently screening a proportion of these,
namely AZ (25%), ZK (25%), JW (25%), KS (25%). We will
resolve any disagreement through discussion and, if required, we
will consult a third review author (JS). We will list studies that
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initially appeared tomeet the inclusion criteria, but which we later
excluded, in the ’Characteristics of excluded studies’ table.We will
collate multiple reports of the same study so that each study rather
than each report is the unit of interest in the review. We will also
provide any information we can obtain about ongoing studies. We
will record the selection process in sufficient detail to complete a
PRISMA flow diagram (Liberati 2009).
Data extraction and management
We will use the EPOC standard data collection form and adapt
it for study characteristics and outcome data (EPOC 2013a). We
will pilot the form on at least one study in the review. Two re-
view authors (ES and AZ) will independently extract the following
study characteristics from the included studies and enter the data
into Review Manager 5 (Review Manager 2014).
• Methods: study design, number of study centres and
location, study setting, withdrawals, date of study, follow-up.
• Participants: number, mean age, age range, gender, socio-
economic status, severity of condition, diagnostic criteria,
inclusion criteria, exclusion criteria, baseline mobility/function,
presence of cognitive impairment, and other relevant
characteristics.
• Interventions: intervention components, comparison,
fidelity assessment, and acceptability of intervention.
• Outcomes: main and other outcomes specified and
collected, time points reported.
• Notes: funding for trial, notable conflicts of interest of trial
authors, ethical approval.
Three review authors (ES, AZ, JW) will independently extract
outcome data from the included studies. This will involve one
review author (ES) independently extracting outcome data from
all included studies, and two authors independently extracting
outcome data for a proportion of these, namely AZ (50%) and JW
(50%). We will note in the ’Characteristics of included studies’
table if outcome data from any included studies were reported in
an unusable way. We will resolve disagreements by consensus or
by involving a third review author (JS).
Assessment of risk of bias in included studies
Two review authors (ES and ZK) will independently assess risk of
bias for each included study using the criteria outlined in Section
8.5 of theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), and the guidance from the EPOC group (EPOC
2013b). We will resolve any disagreements by discussion or by
involving a third review author (JS). We will assess the risk of bias
according to the following domains.
• Random sequence generation
• Allocation concealment
• Blinding of outcome assessment
• Blinding of participants and personnel
• Incomplete outcome data
• Selective outcome reporting
• Baseline outcomes measurement
• Baseline characteristics
• Other bias, such as recruitment bias
We will judge each potential source of bias as high, low, or un-
clear and provide a quote from the study report, together with
a justification for our judgement in ’Risk of bias’ tables. We will
summarise the ’Risk of bias’ judgements across different studies
for each of the domains listed. We will assign an overall ’Risk of
bias’ assessment (high, moderate or low) to each of the included
studies using the approach suggested in Chapter 8 of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011).
Specifically, we will consider studies with low risk of bias for all key
domains, or where it seems unlikely for bias to seriously alter the
results, to have a low risk of bias. We will consider studies to have
an unclear risk of bias where risk of bias in at least one domain
was unclear or judged to have some bias that could plausibly raise
doubts about the conclusions. We will consider studies with a high
risk of bias in at least one domain, or judged to have serious bias
that decreases the certainty of the conclusions, to have a high risk
of bias.
We will consider blinding separately for different key outcomes
where necessary (e.g. for unblinded outcome assessment, risk of
bias for all-cause mortality may be very different than for a patient
reported quality-of-life scale). Where information on risk of bias
relates to unpublished data or correspondence with a trial author,
we will note this in the ’Risk of bias’ tables. We will not exclude
studies on the grounds of their risk of bias, but will report the risk
of bias when presenting the results of the studies.
When considering treatment effects, we will take into account the
risk of bias for the studies that contribute to that outcome.
As we will be including cluster-randomised trials, we will also
consider the following additional biases, as proposed in Chapter
16 of theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011).
• Recruitment bias
• Baseline imbalance
• Loss of clusters
• Incorrect analysis
• Compatibility with individual RTs
• Contamination
We will conduct the review according to this published protocol
and report any deviations from it in the ’Differences between pro-
tocol and review’ section of the systematic review.
Measures of treatment effect
We will estimate the overall effect of the intervention using four
primary outcomes. For dichotomous outcomes (death; living at
home or change in place of residence and adverse events) we will
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use relative risks, and for continuous scores (quality of life) we
will use mean differences or standardised mean differences, with
the corresponding 95% confidence intervals (Higgins 2011). We
will ensure that an increase in scores for all the outcomes can be
interpreted in the same way for each outcome.Wewill also explain
the direction to the reader, and report where the directions were
reversed, if this is necessary. As there is likely to be heterogeneity in
included studies, we will conduct a random-effects meta-analysis.
Unit of analysis issues
Wewill include cluster-RTs in this review. As proposed in Chapter
16 of theCochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011), we will obtain a direct estimate of the required
effect measure, for example, an odds ratio with its corresponding
confidence interval, should the analysis properly account for the
cluster design.
Dealing with missing data
Wewill contact study investigators to obtain anymissing data (e.g.
when a study is identified as abstract only), including to verify key
study characteristics and missing outcome data where possible.
Should it not be possible to obtain complete data, we will report
this as a potential source of bias in the data analyses. We will
assume that all missing data are missing at random, in line with
guidance suggested in Chapter 16 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011).
Assessment of heterogeneity
We will use the I² statistic to measure heterogeneity among the
trials in each analysis. If we identify strong evidence for hetero-
geneity - namely, I² values greater than 75% - we will explore it
by prespecified subgroup analysis (Higgins 2011).
Assessment of reporting biases
We will attempt to contact study authors, asking them to provide
missing outcome data. Where this is not possible, and the missing
data are thought to introduce serious bias, we will explore the
impact of including such studies in the overall assessment of results.
If we are able to pool more than 10 trials, we will create and
examine a funnel plot to explore possible publication biases, and
interpret the results with caution (Sterne 2011).
Data synthesis
We will conduct a random-effects meta-analysis only where this is
meaningful, i.e. if the treatments, participants, and the underlying
clinical question are similar enough for pooling to make sense.
If it is not possible to conduct a meta-analysis we will conduct a
narrative synthesis to summarise the evidence and characteristics
of included studies. Meta-analysis will be considered for feasibility
prior to undertaking the analysis. A common way trial authors
indicate that they have skewed data is by reporting medians and
interquartile ranges. When we encounter this, we will note that
the data are skewed and consider the implication of this. Where
multiple trial arms are reported in a single trial, wewill include only
the relevant arms. If two comparisons (e.g. intervention A versus
usual care and intervention B versus usual care) must be entered
into the same meta-analysis, we will halve the control group to
avoid double-counting.
’Summary of findings’ table and GRADE
In order to draw conclusions about the certainty of the evidence
within the text of the review, wewill create a ’Summary of findings’
table for the main intervention comparisons and the following
outcomes:
• death;
• living at home/change in place of residence;
• quality of life;
• serious adverse events;
• change in function;
• change in health and social care utilisation and costs. .
If during the review process, we become aware of an important
outcome that we failed to list in our planned ’Summary of findings’
table, we will include the relevant outcome and explain the reasons
for this in the section ’Differences between protocol and review’.
Two review authors (ES and ZK) will independently assess the
certainty of the evidence (high, moderate, low, or very low) using
the five GRADE considerations (risk of bias, consistency of effect,
imprecision, indirectness, and publication bias) (Guyatt 2008).
We will use methods and recommendations described in Section
8.5 and Chapter 12 of the Cochrane Handbook for Systematic Re-
views of interventions (Higgins 2011), and the EPOC worksheets
(EPOC 2013c).We will use GRADEproGDT software to do this
(GRADEpro GDT 2014). We will resolve disagreements on cer-
tainty ratings by discussion and provide justifications for decisions
to downgrade or upgrade the ratings using footnotes in the table,
and make comments to aid readers’ understanding of the review
where necessary. We will use plain language statements to report
these findings in the review (EPOC 2013c).
We will consider whether there is any additional outcome infor-
mation that was not possible to incorporate into meta-analyses
and will note this in the comments, stating if it supports or contra-
dicts the information from the meta-analyses. If it is not possible
to meta-analyse the data we will summarise the results in the text.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses.
• Case management which includes care provision versus
models that do not and just consist of co-ordination. This is
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important because different levels and formulations of case
management (i.e. case-finding, comprehensive assessment, care
provision, planning and care giving, care co-ordination,
monitoring and evaluation components) are likely to have a dose
response depending on level and combination of components of
case management, which we would like to test. We will examine
the dose related impact by level of case management (i.e. model
of care or number of staff involved) to ascertain how strong the
effect of case management was in each trial.
• Lower number of visits (i.e. initial assessment and follow-
up) versus multiple visits (i.e. more than two) at different time
points. This is important because our initial review of the
literature showed that studies varied in the number of visits
(face-to-face or telephone contact) provided to frail older people,
indicating a likely dose response, with multiple visits likely to
have better outcomes, which we would like to test. We will
record actual number of visits for each trial in the
’Characterictics of included studies’ table.
• Individuals with mild to moderate versus severe degrees of
frailty. This is important because case management approaches
will have different objectives for those with mild to moderate
degrees of frailty (e.g. healthy living, chronic disease self-
management or even reversal of frailty) compared to those with
severe degrees of frailty (e.g. symptom control or palliation). In
addition, we will consider a subgroup analysis for different
models of frailty (i.e. phenotypical versus accumulative deficit
models), if possible.
• Case management interventions to support frail older
people conducted in high- to middle-income countries versus
those conducted in low-income countries. This is important
because the availability, nature, and scope of health and social
care services, support and integration will vary between countries.
We will use the following outcomes in subgroup analysis.
• Death
• Living at home or change in place of residence
• Quality of life
• Serious adverse events
Furthermore, if data are available we will analyse socio-economic
status, age and gender subgroups as covariates, and adjust analyses
accordingly.
We will perform tests for interaction for subgroup analysis, and
use meta-regression techniques to test for subgroup interactions
providing that sufficient studies (i.e. five or more) are available.
Sensitivity analysis
We will perform sensitivity analyses defined a priori to assess the
robustness of our conclusions and explore its impact on effect sizes.
This will involve the following.
• Restricting the analysis to published studies.
• Restricting the analysis to studies with a low risk of bias, as
specified in Section 13.2.1, Chapter 8 of the Cochrane Handbook
for Systematic Reviews of interventions (Higgins 2011).
• Imputing missing data.
• Analysis by ten-year publication band to account for likely
changes over time.
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A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (OVID)
MEDLINE (including epub ahead of print, in-process & other non-indexed citations 1946 to present).
No. Search terms
1 “aged, 80 and over”/
2 aged/
3 frail elderly/
4 geriatrics/
5 “health services for the aged”/
6 ((geriatric? or senior? or elderly or old*) adj2 (person? or people or adult? or patient?)).ti,ab
7 (frail* adj2 (adult* or elder* or old or senior? or person? or people or patient?)).ti,ab
8 or/1-7
9 exp delivery of health care, integrated/
10 (integrat* adj1 (care or pathway* or service* or delivery or healthcare or program* or approach* or model*)).ti,ab
11 (deliver* adj1 (care or healthcare or service*)).ti,ab.
12 ((system or systems) adj1 (care or healthcare or service*)).ti,ab
13 ((organis* or organiz*) adj1 (care or healthcare or service*)).ti,ab
14 patient care planning/
15 ((coordinat* or co-ordinat*) adj2 (care or healthcare or service* or program* or approach* or management or team care or
team treatment* or team assessment* or team consultation*)).ti,ab
16 case management/
17 ((case or care) adj manag*).ti,ab.
18 (comanag* or co-manag*).ti,ab.
19 comprehensive health care/
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(Continued)
20 (comprehensive adj2 (healthcare or care)).ti,ab.
21 care navig*.ti,ab.
22 (collaborat* adj1 (care or manage* or healthcare or service* or program* or approach* or working)).ti,ab
23 shared care.ti,ab.
24 (holistic adj2 (care or healthcare)).ti,ab.
25 ((partner* or joint) adj2 (care or working)).ti,ab.
26 (“health* and social care” or “medical care and social care” or “care and social care”).ti,ab
27 (team* adj2 (care or treatment* or assessment* or consultation* or healthcare or service* or program* or approach*)).ti,ab
28 ((multidisciplinary or multi-disciplinary or interprofessional or inter-professional or interdisciplinary or inter-disciplinary or
multispeciality or multi-speciality or multiagency or multi-agency or interagency or inter-agency or multi-professional or
mulitprofessional or interorganisation* or interorganization* or inter-organisation* or inter-organization* or multiagenc* or
multi-agenc* or interagenc* or inter-agenc*) adj2 (team* or care or working or collaboration or intervention* or management
or provider? or consultation? or approach* or program* or treatment*)).ti,ab
29 kaiser permanente.ti,ab.
30 or/9-29
31 8 and 30
32 exp randomized controlled trial/
33 controlled clinical trial.pt.
34 randomi#ed.ti,ab.
35 placebo.ab.
36 randomly.ti,ab.
37 clinical trials as topic.sh.
38 trial.ti.
39 or/32-38
40 exp animals/ not humans/
41 39 not 40
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(Continued)
42 31 and 41
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N O T E S
This protocol is based on standard text and guidance provided by Cochrane Effective Practice and Organisation of Care ( EPOC).
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